ARBs used for the treatment of hypertension and their respective strengths, formulations, and doses.
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
In contrast with current guidelines, non-conventional physical activity patterns reduce all-cause, cardiovascular disease (CVD), and cancer mortality.
Clinicians may need to be more proactive in preventing and treating cardiovascular disease in patients with prostate cancer who are receiving ADT.
Stroke risk found highest first three months after cancer diagnosis.
Onartuzumab with weekly paclitaxel with or without bevacizumab does not prolong the corrected QT (QTc) interval.
Prediagnostic Use of Warfarin No Effect on Mortality for Breast, Colorectal, Lung and Prostate CancersDecember 23, 2014
Warfarin sodium is an oral anticoagulant that has been shown in pre-clinical studies to inhibit the spread of cancer cells.
The protein Sirtuin3 was linked to the development of pulmonary hypertension.
Vigorous exercise may lower cardiovascular risk in adult survivors of childhood Hodgkin's lymphoma.
New data show a high prevalence of coronary artery disease among survivors of Hodgkin lymphoma.
Hypertension dosing chart for combination antihypertensive medications.
Managing dyslipidemia, LDL-C Goals, LDL-C versus Non-HDL-C Goals, and management of low HDL-C.
Patients with breast cancer are living longer after treatment; however, with these therapies comes risk for cardiovascular problems.
Intra-arterial therapy is associated with promising locoregional control rates among patients with intrahepatic chloangiocarcinoma, according to research presented at SSO 2013.
Hypertension dosing regiment chart for loop, potassium-sparing, and thiazide-like diuretics.
Beta-blocker pharmacokinetics comparison chart for hypertension.
Calcium channel blockers (CCB) used to treat hypertension (HTN) including benzothiazepines, dihydropyridines, and diphenylalkylamines.
Angiotensin-Converting Enzyme (ACE) Inhibitors and ACEI Combination Therapy Hypertension Dosing Chart.
BP classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes.
Patients treated with dabigatran who experienced major bleeding had a better prognosis than those taking warfarin, investigators reported during the 54th American Society of Hematology Annual Meeting and Exposition.
Persistent and late symptoms are linked to one or more cardiovascular disease risk factors.
Patients had increased risk of suicide and cardiovascular (CV) death following diagnosis of cancer vs. those who were cancer-free.
Vitamin D supplementation can reduce the risk of fracture and cancer; and although there is a biological association between vitamin D deficiency and cardiovascular disease (CVD), there is no evidence that vitamin D supplementation prevents CVD.
Step by step approach to managing hypertension including which anti-hypertensives should be initiated and when to adjust therapy.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- CAR-T Trial for Triple-Negative Breast Cancer Under Way
- Adjuvant Trastuzumab Emtansine Confers Improved Outcome in KATHERINE Trial
- Daratumumab Combination: New Standard of Care in Transplant-Ineligible Multiple Myeloma
- Extension of Adjuvant Anastrozole Regimen to 10 Years Yields Higher DFS, but Not OS
- Phase 3 GEICAM/CIBOMA Results: Adjuvant Capecitabine in Triple-Negative Breast Cancer
- Risk Score Identifies Adjuvant Chemotherapy Toxicity Risk in Elderly Patients With Breast Cancer
- Despite Breast-Conserving Surgery Eligibility, Nearly 50% of Women Chose Mastectomy
- Lisinopril and Carvedilol May Reduce Cardiotoxicity During Adjuvant Trastuzumab Treatment
- Immune Marker Identified as Prognostic in Triple-Negative Breast Cancer
- Rates of Adverse Events Similar Regardless of IMRT Boost Type